Bond.az White LogoBond.az Black Logo
→
EN ▾
AZENRU
Netanyahu to run again in upcoming electionsRussian court confirms sentence for Armenian bloggerIncentives in the Great Return programRussian ambassador returns to YerevanTrump: Erdoğan is my very good friendIAEA adopts resolution against IranAraz Nasirov leaves his post at TABIBExtra revenues directed to reservesSpecial session at Nine Senses Fest 2026Andrea Bocelli to Perform at 2026 WC OpeningNetanyahu to run again in upcoming electionsRussian court confirms sentence for Armenian bloggerIncentives in the Great Return programRussian ambassador returns to YerevanTrump: Erdoğan is my very good friendIAEA adopts resolution against IranAraz Nasirov leaves his post at TABIBExtra revenues directed to reservesSpecial session at Nine Senses Fest 2026Andrea Bocelli to Perform at 2026 WC Opening
Personalize
Bond.az White LogoBond.az Black Logo
AZENRU

#retatrutide

Latest news and interesting information about retatrutide.

Leerink Reaffirms Eli Lilly Stock Rating on Gene Therapy
2026-05-26 08:00
|
677

Leerink Reaffirms Eli Lilly Stock Rating on Gene Therapy

Leerink reaffirms Eli Lilly stock rating with Outperform and $1,119 target, citing promising gene therapy data from VERVE-102 trial. Bond.az covers the latest.

ANALYST RATINGS →
0
Retatrutide Shows 28.3% Weight Loss
2026-05-21 11:03
|
607

Retatrutide Shows 28.3% Weight Loss

Eli Lilly's retatrutide achieves 28.3% weight loss in Phase 3 TRIUMPH-1 trial. New hope for obesity treatment.

COMPANY →
0
...